Vanda Pharmaceuticals Inc
(NAS:VNDA)
$
6.21
-0.02 (-0.32%)
Market Cap: 361.41 Mil
Enterprise Value: -22.64 Mil
PE Ratio: 0
PB Ratio: 0.66
GF Score: 80/100 - Q1 2024 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$5.36 (-2.19%)Earnings
- Q4 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2024$3.64 (-2.41%)Earnings
- Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$4.33 (-2.26%)Earnings
- Q2 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 27, 2023$6.46 (-0.77%)Earnings
- Q1 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2023$6.39 (-0.47%)Earnings
- Q4 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 08, 2023$7.15 (-5.42%)Earnings
- Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022$10.31 (-3.10%)Earnings
- Q2 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2022$10.8 (+3.55%)Earnings
- Vanda Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$9.8 (-4.20%)Earnings
- Q4 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 23, 2022$13.07 (-2.46%)Earnings
- Q3 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021$21.14 (+2.67%)Earnings
- Q2 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 28, 2021$19.53 (+1.19%)Earnings
- Vanda Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$16.58 (-0.48%)Earnings
- Q4 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2021$15.41 (-0.58%)Earnings
- Q3 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptOct 28, 2020$10.09 (-4.77%)Earnings
- Q2 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020$11.02 (+1.75%)Earnings
- Vanda Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020$11.69 (-0.51%)Earnings
- Q4 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2020$11.47 (-2.42%)Earnings
- Q3 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019$13.14 (-2.67%)Earnings
- Q2 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 31, 2019$12.45 (-1.58%)Earnings
- Q1 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 01, 2019$16 (-1.78%)Earnings
Vanda Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 03:00PM GMT
Release Date Price:
$18.41
(+3.43%)
Olivia Simone Brayer
BofA Securities, Research Division - Associate
All right. Good morning, everyone, and welcome to our final day of our BofA Virtual -- BofA Health Care Conference. My name is Olivia Brayer, and I'm on the U.S. biopharma team here at Bank of America. And we're very happy to have with us today, the CEO of Vanda Pharmaceuticals, Mihales Polymeropoulos. We did just launch on Vanda earlier this week, so let us know if you need our model or report. Happy to send either of those. But thanks so much for being with us today, Mihales.
Mihael H. Polymeropoulos
Vanda Pharmaceuticals Inc. - Founder, President, CEO & Director
Thank you, Olivia.
Olivia Simone Brayer
BofA Securities, Research Division - Associate
Yes. And just quickly before we begin, Vanda does have their latest corporate deck on the webcast. So feel free to check that out during the Q&A. You can also submit questions for Mihales and the Vanda team via the link.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)